{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:05:32Z","timestamp":1778295932882,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000008","name":"David and Lucile Packard Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.contraception.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T16:34:59Z","timestamp":1551458099000},"page":"272-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial"],"prefix":"10.1016","volume":"99","author":[{"given":"Wendy R.","family":"Sheldon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana G.","family":"Dzuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Sayette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica C\u00e1rdenas","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2019.02.002_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2015.01.005","article-title":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days","volume":"91","author":"Gatter","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2015.06.018","article-title":"Outpatient medical abortion is safe and effective through 70 days gestation","volume":"92","author":"Abbas","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0025","series-title":"Safe abortion: technical and policy guidance for health systems","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.contraception.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ijgo.12181","article-title":"FIGO's updated recommendations for misoprostol used alone in gynecology and obstetrics","volume":"138","author":"Morris","year":"2017","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2012.10.020","article-title":"Misoprostol in women's hands: a harm reduction strategy for unsafe abortion","volume":"87","author":"Hyman","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijgo.2012.04.002","article-title":"Harm reduction, human rights, and access to information on safer abortion","volume":"118","author":"Erdman","year":"2012","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.contraception.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/AOG.0000000000003017","article-title":"Efficacy of misoprostol alone for first trimester medical abortion: a systematic review","volume":"133","author":"Raymond","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.02.002_bb0050","author":"Guttmacher Institute"},{"issue":"6","key":"10.1016\/j.contraception.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/13625187.2013.824564","article-title":"Medical abortion: a path to safe, high-quality abortion care in Latin America and the Caribbean","volume":"18","author":"Dzuba","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-4755-9-34","article-title":"Latin American women's experiences with medical abortion in settings where abortion is legally restricted","volume":"9","author":"Zamberlin","year":"2012","journal-title":"Reprod Health"},{"key":"10.1016\/j.contraception.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1471-0528.2005.00704.x","article-title":"Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association","volume":"112","author":"Miller","year":"2005","journal-title":"BJOG"},{"issue":"24 Suppl","key":"10.1016\/j.contraception.2019.02.002_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0968-8080(04)24010-1","article-title":"Misoprostol alone for early medical abortion in a Latin American clinic settings","volume":"12","author":"Billings","year":"2004","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.contraception.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2307\/2939191","article-title":"The Brazilian experience with Cytotec","volume":"24","author":"Barbosa","year":"1993","journal-title":"Stud Fam Plan"},{"key":"10.1016\/j.contraception.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(07)60914-3","article-title":"Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial","volume":"369","author":"von Hertzen","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.contraception.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2005.02.019","article-title":"Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone","volume":"123","author":"Arvidsson","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2019.02.002_bb0090","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/j.ijgo.2007.09.006","article-title":"Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy","volume":"99","author":"Fa\u00fandes","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.contraception.2011.05.131","article-title":"Buccal use of misoprostol alone for early abortion: the experience in four Latin American countries","volume":"84","author":"Sayette","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2019.02.002_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1728-4465.2011.00277.x","article-title":"Patient characteristics and service trends following abortion legalization in Mexico City, 2007\u201310","volume":"42","author":"Mondrag\u00f3n y Kalb","year":"2011","journal-title":"Stud Fam Plan"},{"key":"10.1016\/j.contraception.2019.02.002_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.09.002","article-title":"Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone","volume":"83","author":"Ngoc","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijgo.2012.03.039","article-title":"Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam","volume":"118","author":"Blum","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00404-011-2110-8","article-title":"Efficacy and safety of mifepristone and buccal misoprostol versus buccal misoprostol alone for medical abortion","volume":"285","author":"Dahiya","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.contraception.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.contraception.2016.12.004","article-title":"Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis","volume":"95","author":"Raymond","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2019.02.002_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2006.03.005","article-title":"The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion","volume":"74","author":"Tang","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2019.02.002_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/13625187.2016.1168799","article-title":"A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes","volume":"21","author":"Frye","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2019.02.002_bb0145","series-title":"Medical management of abortion","year":"2018"},{"key":"10.1016\/j.contraception.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.contraception.2008.06.002","article-title":"Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac","volume":"78","author":"Reeves","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.002_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijgo.2006.10.009","article-title":"Vaginal misoprostol for salvage therapy after failed medical abortion","volume":"96","author":"Li","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.contraception.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/AOG.0b013e3182707341","article-title":"Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis","volume":"120","author":"Elati","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2019.02.002_bb0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2012.09.022","article-title":"A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation","volume":"87","author":"Chai","year":"2013","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419300368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419300368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:14:05Z","timestamp":1757880845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782419300368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0010782419300368"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2019.02.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}